The ACCC Oncology Reimbursement Meetings (ORMs) help all members of the multidisciplinary cancer care team navigate the annual changes in oncology reimbursement and regulations
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
The ACCC Oncology Reimbursement Meetings (ORMs) help all members of the multidisciplinary cancer care team navigate the annual changes in oncology reimbursement and regulations— while improving their knowledge on effective strategies for success in an everchanging oncology landscape. In this episode, CANCER BUZZ speaks with Jordan Karwedsky, financial counselor, Green Bay Oncology, about her session at the ORMs last fall, where she discussed best practices cancer care teams can adopt as they prepare for the open enrollment season.
“If you have a patient who is uninsured or underinsured, make a note that is a reminder for you so come November when open enrollment begins, you can reach out to them and help them optimize their insurance. In the meantime, if they need treatment, then work with the drug companies to save them as much money on their treatment.”
“Highlights from recent ORMs include how to work with your legislature, either at the state or federal level, to advocate for laws that will help patients.”
Guests:


Jordan Karwedsky
Financial Counselor
Green Bay Oncology
In one of the upcoming ORMs this spring, Karwedsky will share strategies for patient navigation in the digital age. For more information, please visit the ACCC website.
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026

At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
